A daily news update on our COVID-19 coverage.
Hello and thank you for joining Contagion. I’m assistant editor Grant Gallagher, here with an infectious disease news brief.
Researchers and epidemiologists are working tirelessly to understand clusters that shed new insight into transmission dynamics.A recent CDC Morbidity and Mortality Weekly Report or “MMWR” focused on Learning from a Choir's SARS-CoV-2 Exposure Cluster. Singing while 6-10 inches from one another could be a risky exposure, according to authors of the report.
Today we also shared an interview with Dr. Adam Brufsky, an oncologist who has worked with infectioius disease researchers to contribute new theories on COVID. In this second part of our interview, Dr. Brufsky moves from talking about glycosolation of the SARS-CoV-2 spike protein to emerging evidence about the potential for multiple strains of the coronavirus.
And as a reminder, yesterday we shared an interview with Dr. Armand Balboni, CEO of a biotechnology company that’s working with FUJIFILM Toyama Chemical on its favipiravir treatment, which is approved in Japan as an antiviral, on a new front for the drug — the global search for a pandemic treatment that can both prevent and combat COVID-19
For more on these stories and other infectious disease news, visit contagionlive.com.